These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2849616)

  • 1. Atopic dermatitis: influence of bacterial infections on human monocyte and neutrophil granulocyte functional activities.
    Mrowietz U; Konter U; Traut R; Schröder JM; Christophers E
    J Allergy Clin Immunol; 1988 Dec; 82(6):1027-36. PubMed ID: 2849616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C5a-specific modulation of phagocyte functions in patients with localized bacterial infections.
    Mrowietz U; Christophers E; Schröder JM
    Immunobiology; 1987 Aug; 174(4-5):460-72. PubMed ID: 2824343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of human monocyte functions during acute bacterial infection.
    Mrowietz U; Christophers E
    Scand J Immunol; 1988 Aug; 28(2):139-46. PubMed ID: 2842855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of neutrophil superoxide production in sepsis.
    Solomkin JS; Cotta LA; Brodt JK; Hurst JM
    Arch Surg; 1985 Jan; 120(1):93-8. PubMed ID: 2981524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B.
    Senior RM; Skogen WF; Griffin GL; Wilner GD
    J Clin Invest; 1986 Mar; 77(3):1014-9. PubMed ID: 3005361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-enhanced leukotriene B4 generation and chemotaxis in human neutrophils.
    Meyer JD; Yurt RW; Duhaney R; Hesse DG; Tracey KJ; Fong YM; Verma M; Shires GT; Dineen P; Lowry SF
    Arch Surg; 1988 Dec; 123(12):1454-8. PubMed ID: 2847685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient absence of C5a-specific neutrophil function in inflammatory disorders of the skin.
    Schröder JM; Christophers E
    J Invest Dermatol; 1985 Sep; 85(3):194-8. PubMed ID: 3161955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
    Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective monocyte and polymorphonuclear leukocyte chemotaxis and clinical characteristics in atopic dermatitis.
    Ternowitz T; Herlin T
    Arch Dermatol Res; 1986; 278(6):454-9. PubMed ID: 3789804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional inhibition by anthralin in nonstimulated and chemotactic factor stimulated human neutrophils.
    Schröder JM; Kosfeld U; Christophers E
    J Invest Dermatol; 1985 Jul; 85(1):30-4. PubMed ID: 2989375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophil migration in atopic dermatitis. I: Increased migratory responses to N-formyl-methionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet-activating factor, and platelet factor 4.
    Bruijnzeel PL; Kuijper PH; Rihs S; Betz S; Warringa RA; Koenderman L
    J Invest Dermatol; 1993 Feb; 100(2):137-42. PubMed ID: 8429236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infiltrating neutrophils differ from circulating neutrophils when stimulated with C5a, NAP-1/IL-8, LTB4 and FMLP.
    Mrowietz U; Schröder JM; Brasch J; Christophers E
    Scand J Immunol; 1992 Jan; 35(1):71-8. PubMed ID: 1310358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
    Harvath L; McCall CE; Bass DA; McPhail LC
    J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
    Webster RO; Goldstein IM; Flick MR
    J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphonuclear leukocytes cap a derivative of wheat germ agglutinin upon stimulation with formyl peptide and C5a but not leukotriene B4.
    Kurrasch R; Elfman F; Perez HD
    J Immunol; 1989 Sep; 143(6):1969-73. PubMed ID: 2550548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
    Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
    Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent regulation of human neutrophil chemotactic receptors after activation.
    Bender JG; Van Epps DE; Chenoweth DE
    J Immunol; 1987 Nov; 139(9):3028-33. PubMed ID: 2822801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-3, interleukin-8, FMLP and C5a enhance the release of leukotrienes from neutrophils of patients with atopic dermatitis.
    Neuber K; Hilger RA; König W
    Immunology; 1991 May; 73(1):83-7. PubMed ID: 2045129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent regulation of leukotriene B4-elicited polymorphonuclear leukocyte exocytosis and superoxide generation by a serum factor.
    Mandell BF
    J Leukoc Biol; 1987 Apr; 41(4):318-24. PubMed ID: 3033108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A monoclonal antibody-inhibiting FMLP-induced chemotaxis of human neutrophils.
    Cotter TG; Keeling PJ; Henson PM
    J Immunol; 1981 Dec; 127(6):2241-5. PubMed ID: 7053244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.